Skip to main content

Advertisement

Antinuclear antibodies (ANA) in a Colombian cohort of pediatric patients with autoimmune diseases (PAID)

Article metrics

  • 664 Accesses

Background

ANA is an important diagnostic tool in PAID. The type of staining patterns by IFF technique and the final titer varies according of the type of PAID.

Aim

To evaluate the ANA type of patterns and titer on a cohort of PAID patients in a referral pediatric rheumatology center in Bogotá.

Methods

Retrospective descriptive study of a PAID cohort.

Results

363 patients were included. 66% had JIA, 11% JSLE, 7% juvenile undifferentiated autoimmune disease(JUAD), 4% Scleroderma, 4% JDM, 1% uveitis ANA + and a group of other PAID 11%. ANA positivity varies according to the subtype of JIA from 0-68%. Positive AAN: JSLE 93%, scleroderma 85%, JDM 63%. Most JUAD had ANA+ at low titers. A heterogeneous group of other PAID showed a variable titers and patterns of ANA .The most prevalent type of pattern was speckled, followed by homogenous and other pattern were uncommon. On JSLE, the prevalence and titers were higher and multiple auto antibodies were detected at the time of diagnosis. (Table 1).

Table 1 Table 1

Conclusion

ANA positivity is not specific for PAID. Its interpretation should be based on a good clinical correlation and additional work up in order to classified and confirm PAID.

Author information

Correspondence to MD Yepez Ricardo.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Ricardo, M.Y., Clara, M.M., Romero-Sanchez, C. et al. Antinuclear antibodies (ANA) in a Colombian cohort of pediatric patients with autoimmune diseases (PAID). Pediatr Rheumatol 9, P230 (2011) doi:10.1186/1546-0096-9-S1-P230

Download citation

Keywords

  • Uveitis
  • Scleroderma
  • Antinuclear Antibody
  • Clinical Correlation
  • Pediatric Rheumatology